Pandox AB (LTS:0R8U)
kr 175.1 +0.20 (+0.11%) Market Cap: 33.82 Bil Enterprise Value: 86.97 Bil PE Ratio: 10.72 PB Ratio: 0.98 GF Score: 73/100

Q2 2025 Pandox AB Earnings Call Transcript

Jul 11, 2025 / 06:30AM GMT
Release Date Price: kr165.3 (-0.84%)

Key Points

Positve
  • Pandox AB (PNDXF) reported a stable second quarter with total revenues increasing by 2%, net operating income up by 3%, and cash earnings rising by 5%.
  • Acquisitions, including the Pullman Cologne Hotel and a new lease for Numa Brussels Royal Galleries, contributed positively to the company's performance.
  • The company maintains a strong financial position with a loan-to-value ratio of 46.7% and significant capacity for new acquisitions and investments.
  • Pandox AB (PNDXF) has a well-diversified hotel property portfolio with 163 properties across 11 countries, valued at SEK76 billion.
  • The company continues to benefit from a constructive financing climate with lower credit margins and expanding bank relations across markets.
Negative
  • Cash earnings per share decreased by 1% despite overall growth in cash earnings.
  • The Own Operations segment experienced a decline in like-for-like revenues and net operating income by 3% and 4%, respectively, due to lower average daily rates.
  • The company faced tough comparables from the previous year, including events like the UEFA European Championships and Taylor Swift's Eras Tour, which impacted performance.
  • Currency fluctuations negatively impacted income statement items, although they had a positive effect on balance sheet items.
  • The intended bid for Dalata Hotel Group was rejected by Dalata's Board of Directors, creating uncertainty around this potential acquisition.
Anders Berg
Pandox AB - Senior Vice President, Head of Communications and Investor Relations

Thank you very much. Welcome, everyone, to this presentation of Pandox interim report for the second quarter and first half year 2025. I'm here together with Liia Nou, our CEO; and Anneli Lindblom, our CFO. And today, we also have the pleasure of having both Alex Robinson, Director at STR; and Henrik Karlsson, Business Development Manager at Benchmarking Alliance with us. And Alex and Henrik will provide a hotel market update on Europe and Nordics, respectively.

As you know, STR and Benchmarking Alliance are both leading independent research firms dedicated to the hotel market, and the views they express are completely separate from Pandox. And we offer these presentations as a service to Pandox stakeholders. And as always, Alex and Henrik's presentations will be held after we have completed our formal earnings presentation, including the Q&A. So we start with Liia and Anneli's business update and financial highlights for the second-quarter 2025, followed by the Q&A session.

Yes, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot